Articles By Jack Cush, MD
Canakinumab Use in Periodic Febrile Disorders
By Jack Cush, MD
16 September 2021
A retrospective records review of patients with periodic fever syndromes (PFS) receiving IL-1 inhibitor treatment with canakinumab (CAN), shows CAN to be effective and safe in a variety of PFS patients.
Read Article
Effect of Diet on COVID Outcomes
By Jack Cush, MD
15 September 2021
A smartphone-based symptom study of COVID-19 patients has shown that a healthy plant-based diet was associated with lower risk and severity of COVID-19, especially amongst those living in areas with higher socioeconomic deprivation.
Read Article
Different Regimens but Equal Outcomes in Polyarticular JIA
By Jack Cush, MD
15 September 2021
CARRA (Childhood Arthritis and Rheumatology Research Alliance) has compared 3 different treatment strategies for polyarticular JIA to identify the optimal time to biologic regimen.
Read Article
High Drug Switching and Low Persistence in Rheumatoid Arthritis
By Jack Cush, MD
13 September 2021
Mease and colleagues have catalogued the current practices assessed in the CORRONA registry, noting that increased DMARD switching and decreased time on a given therapy by US physicians.
Read Article
RheumNow Podcast – High Science and Future Treatments (9.10.2021)
By Jack Cush, MD
10 September 2021
This week: high science that affect future treatments; breakthrough infections in our patients, and what's up with that; and soon your radiologist is going to be replaced by AI. This and more in our review of the news and journal articles from the past week.
Read Article
FDA Review of Vaping Products Extended
By Jack Cush, MD
09 September 2021
The FDA has again extended its decision on whether the manufacturers of vaping products can market their e-cigarettes in the United States.
Read Article
Risk Factors Associated with Systemic Sclerosis Hospitalization
By Jack Cush, MD
09 September 2021
A retrospective study of systemic sclerosis patients shows that acute hospitalization and mortality were not uncommon and were often linked to SSc-related lung disease.
Read Article
COVID Breakthrough Infections in Rheumatic Patients
By Jack Cush, MD
08 September 2021
Analysis of records from the Mass General Brigham healthcare system in the Boston area, shows that breakthrough infections (after receiving SARS-CoV-2 vaccines) in patients with systemic autoimmune rheumatic diseases (SARDs) are not uncommon, and may be severe or fatal.
Read Article
Diagnostic Delay in Half of Psoriatic Arthritis Patients
By Jack Cush, MD
07 September 2021
A Mayo Clinic/ Olmsted County study of psoriatic arthritis (PsA) patients has shown that more than half (55%) of PsA patients had a diagnostic delay of > 2 years, and that this delay has not improved over time.
Read Article
ICYMI: The Greatest Rheumatologist - Part II
By Jack Cush, MD
06 September 2021
Wow! I hope you read part I of yesterday's “Greatest Rheumatologist” article. So many big names and yet, other names and stories that were equally inspirational. If you read the comments of the part I article you can clearly see several themes emerge.
Read Article